Table 4.
Univariate and multivariate analysis of prognostic factors for overall survival (n = 118)
| Characteristics | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p value | OR | 95% CI | p value | |
| Age, years | ||||||
| <60 | 1 (Ref) | - | - | |||
| ≥60 | 1.314 | 0.663-2.604 | 0.434 | |||
| FIGO stage | ||||||
| I | 1 (Ref) | - | - | 1 (Ref) | - | - |
| II-IV | 3.616 | 1.820-7.186 | < 0.001* | 2.980 | 1.487-5.974 | 0.002* |
| LVSI | ||||||
| No | 1 (Ref) | - | - | 1 (Ref) | - | - |
| Yes | 2.935 | 1.514-5.687 | 0.001* | 1.413 | 0.562-3.553 | 0.462 |
| LN metastasis | ||||||
| No | 1 (Ref) | - | - | 1 (Ref) | - | - |
| Yes | 2.786 | 1.472-5.273 | 0.002* | 0.822 | 0.294-2.297 | 0.708 |
| NLR | ||||||
| < 1.316 | 1 (Ref) | - | - | 1 (Ref) | - | - |
| ≥ 1.316 | 3.048 | 1.081-8.594 | 0.035* | 1.365 | 0.454-4.102 | 0.579 |
| PLR | ||||||
| < 132.4 | 1 (Ref) | - | - | 1 (Ref) | - | - |
| ≥ 132.4 | 2.427 | 1.224-4.812 | 0.011* | 1.590 | 0.775-3.260 | 0.206 |
| MLR | ||||||
| < 0.191 | 1 (Ref) | - | - | 1 (Ref) | - | - |
| ≥ 0.191 | 3.854 | 1.610-9.225 | 0.001* | 2.941 | 1.210-7.147 | 0.017* |
Covariates with p < 0.05 on univariate analysis were included in multivariate model.OR, odds ratio; CI, confidence interval; Ref, reference; FIGO, International Federation of Gynecology and Obstetrics; LVSI, lymphovascular space invasion; LN, lymph node; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; MLR, monocyte-to-lymphocyte ratio.